Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimation of State Variables and Model Parameters for the Evolution of COVID-19 in the City of Rio de Janeiro

View ORCID ProfileHelcio R. B. Orlande, View ORCID ProfileMarcelo J. Colaço, View ORCID ProfileGeorge S. Dulikravich, Luiz Ferreira
doi: https://doi.org/10.1101/2020.05.21.20108407
Helcio R. B. Orlande
1Department of Mechanical Engineering - Politécnica/COPPE Federal University of Rio de Janeiro, UFRJ Cx. Postal: 68503, 21941-972, Rio de Janeiro, Brazil; ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helcio R. B. Orlande
  • For correspondence: helcio{at}mecanica.coppe.ufrj.br helcio{at}mecanica.coppe.ufrj.br colaco{at}mecanica.coppe.ufrj.br
Marcelo J. Colaço
1Department of Mechanical Engineering - Politécnica/COPPE Federal University of Rio de Janeiro, UFRJ Cx. Postal: 68503, 21941-972, Rio de Janeiro, Brazil; ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marcelo J. Colaço
  • For correspondence: helcio{at}mecanica.coppe.ufrj.br colaco{at}mecanica.coppe.ufrj.br
George S. Dulikravich
2Department of Mechanical and Materials Engineering Florida International University, College of Engineering Multidisciplinary Analysis, Inverse Design, Robust Optimization and Control (MAIDROC) Laboratory 10555 West Flagler Street, Miami, Florida 33174, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for George S. Dulikravich
  • For correspondence: dulikrav{at}fiu.edu
Luiz Ferreira
1Department of Mechanical Engineering - Politécnica/COPPE Federal University of Rio de Janeiro, UFRJ Cx. Postal: 68503, 21941-972, Rio de Janeiro, Brazil; ,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: helcio{at}mecanica.coppe.ufrj.br colaco{at}mecanica.coppe.ufrj.br
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

SUMMARY

  • Evolution model is based on that used by Hernandez et al. [1], which considers the following groups: Susceptible, Incubating, Asymptomatic, Symptomatic, Hospitalized, Recovered and Accumulated deaths.

  • Evolution model considers the possibility of infections from asymptomatic, symptomatic and hospitalized individuals.

  • Evolution model considers the possibility that individuals who have recovered from the disease become symptomatic again.

  • Observation model accounts for underreport of cases and deaths.

  • Observation model accounts for delays in reporting cases and deaths.

  • Model parameters were initially estimated with the Markov Chain Monte Carlo (MCMC) method [2,3], by using the data of the city of Rio de Janeiro [4] from February 28, 2020 to April 29, 2020. These estimations were used as initial input values for the solution of the state estimation problem for the city of Rio de Janeiro.

  • Algorithm of Liu & West for the Particle Filter [5] was used for the solution of the state estimation problem because it allows the simultaneous estimation of state variables and model parameters.

  • State estimation problem was solved with the data of the city of Rio de Janeiro [4], from February 28, 2020 to May 05, 2020.

  • Monte Carlo simulations were run for 20 future days, considering uncertainties in the model parameters and state variables. Initial conditions were given by the state variables and corresponding distributions estimated with the particle filter on May 05, 2020. Distributions of the model parameters were also given by the estimations obtained for this date.

  • Data of the city of Rio de Janeiro [4], from May 06, 2020 to May 15, 2020, were used for the validation of the solution of the state estimation problem.

  • The present model, with the parameters obtained with the Particle Filter, accurately fits the number of reported cases and the number of reported deaths, for 10 days ahead of the period used for the solution of the state estimation problem.

  • The Ratio of Infected Individuals per Reported Cases was around 15 on May 05, 2020.

  • The Indexes of Under-Reported Cases and Deaths were around 12 and 2, respectively, on May 05, 2020.

  • The Effective Reproduction Number was around 1.6 on February 28, 2020 and dropped to around 0.9 on May 05, 2020. However, uncertainties related to this parameter are large and the effective reproduction number is between 0.3 and 1.5, at the 95% credibility level.

  • The particle filter must be used to periodically update the estimation of state variables and model parameters, so that future predictions can be made.

  • Day 0 is February 28, 2020.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

CNPq CAPES FAPERJ

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Only public data available online has been used, as referenced in the manuscript.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Only public data has been used, as referenced in the manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimation of State Variables and Model Parameters for the Evolution of COVID-19 in the City of Rio de Janeiro
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimation of State Variables and Model Parameters for the Evolution of COVID-19 in the City of Rio de Janeiro
Helcio R. B. Orlande, Marcelo J. Colaço, George S. Dulikravich, Luiz Ferreira
medRxiv 2020.05.21.20108407; doi: https://doi.org/10.1101/2020.05.21.20108407
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Estimation of State Variables and Model Parameters for the Evolution of COVID-19 in the City of Rio de Janeiro
Helcio R. B. Orlande, Marcelo J. Colaço, George S. Dulikravich, Luiz Ferreira
medRxiv 2020.05.21.20108407; doi: https://doi.org/10.1101/2020.05.21.20108407

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (758)
  • Anesthesia (222)
  • Cardiovascular Medicine (3310)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13396)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5171)
  • Geriatric Medicine (482)
  • Health Economics (785)
  • Health Informatics (3282)
  • Health Policy (1144)
  • Health Systems and Quality Improvement (1198)
  • Hematology (432)
  • HIV/AIDS (1022)
  • Infectious Diseases (except HIV/AIDS) (14649)
  • Intensive Care and Critical Care Medicine (914)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (525)
  • Neurology (4945)
  • Nursing (262)
  • Nutrition (734)
  • Obstetrics and Gynecology (888)
  • Occupational and Environmental Health (796)
  • Oncology (2528)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (546)
  • Pediatrics (1304)
  • Pharmacology and Therapeutics (551)
  • Primary Care Research (558)
  • Psychiatry and Clinical Psychology (4223)
  • Public and Global Health (7524)
  • Radiology and Imaging (1713)
  • Rehabilitation Medicine and Physical Therapy (1017)
  • Respiratory Medicine (981)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (72)
  • Transplantation (237)
  • Urology (206)